Paper4895045
Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.
Adams GE and 1 other. Int J Radiat Biol Relat Stud Phys Chem Med, 1969. Cited by 187 papers, by iCite.
Cite this record
ConductScience Library. Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria. Papers, record 4895045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4895045
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Electron Transport | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Serratia marcescens | Major topic |
| Fumarates | |
| Models, Biological | |
| Models, Chemical | |
| Pyruvates | |
| Quinones | |
| Vitamin K |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34827602 | Targeting Hypoxia: Revival of Old Remedies. | Biomolecules | 2021 | https://conductscience.org/library/papers/34827602 | PubMed |
| 34154610 | Interfering with Tumor Hypoxia for Radiotherapy Optimization. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34154610 | PubMed |
| 30575832 | Hypoxia-targeted drug delivery. | Chem Soc Rev | 2019 | https://conductscience.org/library/papers/30575832 | PubMed |
| 30429888 | Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy. | Theranostics | 2018 | https://conductscience.org/library/papers/30429888 | PubMed |
| 29979089 | Clinical trials targeting hypoxia. | Br J Radiol | 2019 | https://conductscience.org/library/papers/29979089 | PubMed |
| 29303355 | Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes. | Br J Radiol | 2019 | https://conductscience.org/library/papers/29303355 | PubMed |
| 28423594 | The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy. | Oncotarget | 2017 | https://conductscience.org/library/papers/28423594 | PubMed |
| 28030900 | Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy. | Radiat Oncol J | 2016 | https://conductscience.org/library/papers/28030900 | PubMed |
| 26983987 | The impact of hypoxia and its modification of the outcome of radiotherapy. | J Radiat Res | 2016 | https://conductscience.org/library/papers/26983987 | PubMed |
| 26073310 | Modulation of the tumor vasculature and oxygenation to improve therapy. | Pharmacol Ther | 2015 | https://conductscience.org/library/papers/26073310 | PubMed |
| 25243023 | The role of mitochondrial function in gold nanoparticle mediated radiosensitisation. | Cancer Nanotechnol | 2014 | https://conductscience.org/library/papers/25243023 | PubMed |
| 23149893 | Imaging hypoxia to improve radiotherapy outcome. | Nat Rev Clin Oncol | 2012 | https://conductscience.org/library/papers/23149893 | PubMed |
| 8763857 | Radioprotection by DNA ligands. | Br J Cancer Suppl | 1996 | https://conductscience.org/library/papers/8763857 | PubMed |
| 7013776 | Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7013776 | PubMed |
| 6768098 | Time effects in molecular radiation biology. | Radiat Environ Biophys | 1980 | https://conductscience.org/library/papers/6768098 | PubMed |
| 6168277 | Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6168277 | PubMed |
| 465301 | Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions. | Br J Cancer | 1979 | https://conductscience.org/library/papers/465301 | PubMed |
| 375966 | Radiosensitization of E. coli B/r by the cytotoxic agent procarbazine: a hypoxic cell sensitizer preferentially toxic to aerobic cells and easily oxidized. | Br J Cancer | 1979 | https://conductscience.org/library/papers/375966 | PubMed |
| 354671 | A possible combination of hypoxic cell sensitizer with an oxic protector: implications for radiotherapy. | Br J Cancer | 1978 | https://conductscience.org/library/papers/354671 | PubMed |
| 277207 | The rationale for the development of improved hypoxic cell radiosensitizers. | Br J Cancer Suppl | 1978 | https://conductscience.org/library/papers/277207 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4895045
GET https://conductscience.org/api/papers/v1/4895045/authors